5 Contrasting agents; contrast media for in vivo imaging; radiological contrast substances for medical purposes; diagnostic reagents and contrast media for medical use; contrast media for use with imaging medical equipment; contrast media for use with magnetic resonance imaging equipment; contrast media for use with magnetic resonance tomography equipment; diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical agents for use in PET (Positron Emission Tomography) imaging; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; radiopharmaceutical agents for use in amyloid pathology detection; radiopharmaceutical products; radiopharmaceuticals for therapy and diagnostics, radionuclides for therapy and diagnostics; pharmaceuticals, diagnostic radiopharmaceutical agents for use in SPECT (Single-Photon Emission Computed Tomography) imaging; therapeutic radiopharmaceuticals for cancer treatment; therapeutic radiopharmaceuticals for oncology; therapeutic radiopharmaceuticals for cardiology; therapeutic radiopharmaceuticals for neurology; materials for theranostics